Biochips Market Synopsis

Biochips Market Size Was Valued at USD  12.08 Billion in 2023 and is Projected to Reach USD  67.67 Billion by 2032, Growing at a CAGR of 21.10% From 2024-2032.

Biochips are micromechanisms that can carry out numerous biochemical reactions, perhaps even in the numbers of hundreds or thousands at a time. They are applied in high-through put analysis of large numbers of biological analytes for different applications such as diagnostics, drug discovery and for genomic analysis.

• There has been a considerable growth of the biochips market which has been caused by the increase in the need for miniaturized diagnostic equipment and the increase in the use of customized medicine. For these reasons biochips play an important role in modern biotechnology especially in the areas of genomics, proteomics and drug discovery. These devices that enable the control of thousands of biological reactions in parallel provide great advantages in this aspect of efficiency and productivity. Therefore the application of biochips can be observed in such spheres as healthcare, pharmaceuticals, and academic researches for purposes of diagnostics of diseases, drugs development and use of biotechnologies in agriculture.
• Due to the rising incidence of chronic diseases, need for diagnostic technologies, and enhancement in genomics and proteomics, the biochips market around the world is predicted to sustain a healthy growth. Furthermore, the expansion of single chip system, that combines many laboratories functions in a single chip known as lab on chip technology is emerging market for low price portable diagnostic tools. This is further supplemented by the growth of a biochip market, which integrates artificial intelligence, big data analytics with the biochip platform to deliver more personalized treatments.

Biochips Market Trend Analysis

Rising Integration of AI in Biochip Technology

• The incorporation of AI with biochip technology is the emerging phenomena in the market segment. The rapid and efficient data analysis makes AI an ideal partner to the high throughput of biochips, as demonstrated in the following sections. In more specific fields such as genomics and proteomics, AI assists in the vast data produced from biochips, where patterns, biomarkers, and sogar drug targets can be more easily identified.
• This trend can be seen most acutely in the field of personalized medicine, where biochips integrated with AI allow for highly specific diagnostic work to be done on the patient in question. AI helps to improve the results derived from the biochip scans by improving the interpretation algorithms used to analyze them. AI integrated with biochips promises to optimize drug-related processes, lower costs and increase value for treatments with focus on individual patient.

Expanding Applications in Agriculture

• The current and future opportunities for the biochips market include; Agriculture: In the agricultural industry incorporating the application of biochips has the potential to enhance crop production under severe measurements and pests control. Nowadays biochips are used more and more actively in the framework of the agriculture biotechnology for investigation of genomic characteristics of crops providing the identification of specific indicators of disease resistance, water-deficit tolerance and increase of the nutritive value. This aid in breeding the so-called genetically modified organisms (GMOs) and other advances in crop improvement.
• Furthermore, biochips enable accurate measurement of plant pathogen and environmental conditions necessary for the right management of crops. When incorporating the biochip technology into the process of farming, the farmers receive timely information on the health status of the plants, soil quality and pest presence, to make better decisions that will lead to sustainable use of natural resources. This opportunity tells us that biochips have the potential to solve current global food security problems through technological developments in agriculture.

Biochips Market Segment Analysis:

Biochips Market Segmented based on Product Type, Application, and End User.

By   Product Type, DNA Chip segment is expected to dominate the market during the forecast period

• The biochips market is segmented into four main types: Nucleotide chips, peptide and protein chips, lab on chip and others. These DNA chips are primarily used to analyse biological samples, and are therefore a commercial necessity particularly in areas like drugs discovery and diagnostic of diseases. With rising genomic research, DNA chips are predicted to be the key product segment to continue to dominate the biochips business due to the market for personalized medicine and genetic screening tools.
• Lab-on-a-chip is another rapidly developing segment because it is an integration of many complicated laboratory operations into one chip. This technology offers a range of diagnostic results in a short span of time and is becoming popular in POC testing applications. The convenience of lab-on-chip systems in relation to conventional lab structures as well as the implementation of top-quality lab-on-a-chip systems at a low cost to meet personal and research needs will continue to reshape this segment.

By Application , Drug Discovery & Development  segment held the largest share in 2023

• Biochips, or also known as bioarray, are incorporated in various fields; such as, drug discovery and development, disease diagnosis, genomics, proteomics, and agrigenomics. In drug discovery, the biochips fulfill a very important function in high throughput screening which allows the investigator to screen the thousands of compounds at a very high speed. This in a very big way helps to shorten the cycle of drug discovery, making it possible to identify potential drug compounds early. This is an important aspect of pharmaceutical research because it becomes possible to evaluate molecular interactions on a large scale, which is one of the strengths of biochips.
• In diagnostics, the biochips offer fast and precise diagnosis of diseases right from the molecular level. They are of great value for biomarker discovery of cancer, cardiovascular and infectious diseases. Clinical diagnostics is one of the most significant application areas for biochips because of their accuracy and rate of response; further growth of point of care diagnostics will also contribute to expanding uses of the chips.

Biochips Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• For now, the global market for biochips is pioneered by the North American region, courtesy of leading biotechnology industries, sound health care systems, and infrastructure, and emphasis on research and development. The United States has one of the most developed biochip industries due to well-developed academic research facilities and funding of biotechnology applications.
• It also points that the application for=Value Chain Analysis FY15 Page x the region increased because of the trending condition on personalized disease treatment that heavily depends on biochip technology for the genetic analysis of patients. Due to the high rate of chronic diseases and the developed industry for the production of medicines, it is assumed that North America will continue to occupy a leading position in the sales of biochips in the world.

Active Key Players in the Biochips Market

• Illumina, Inc. (USA)
• Agilent Technologies, Inc. (USA)
• Thermo Fisher Scientific, Inc. (USA)
• PerkinElmer, Inc. (USA)
• Bio-Rad Laboratories, Inc. (USA)
• GE Healthcare (USA)
• Fluidigm Corporation (USA)
• F. Hoffmann-La Roche AG (Switzerland)
• Samsung Biologics (South Korea)
• Abbott Laboratories (USA)
• Cepheid (USA)
• Merck KGaA (Germany)
• Randox Laboratories (UK)
• AYOXXA Biosystems GmbH (Germany)
• Micronit Microtechnologies B.V. (Netherlands) and Other key Player

Key Industry Developments in the Biochips Market

• December 2021, University College Dublin (UCD) announced the acquisition of OncoMark Ltd, a UCD spin-out company, by Cepheid Inc., a US molecular diagnostics company.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Biochips Market by Product Type
 4.1 Biochips Market Snapshot and Growth Engine
 4.2 Biochips Market Overview
 4.3 DNA Chip
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 DNA Chip: Geographic Segmentation Analysis
 4.4 Protein Chip
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Protein Chip: Geographic Segmentation Analysis
 4.5 Lab-on-a-chip
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Lab-on-a-chip: Geographic Segmentation Analysis
 4.6 Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Others: Geographic Segmentation Analysis

Chapter 5: Biochips Market by Application
 5.1 Biochips Market Snapshot and Growth Engine
 5.2 Biochips Market Overview
 5.3 Drug Discovery & Development
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Drug Discovery & Development: Geographic Segmentation Analysis
 5.4 Disease Diagnostics
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Disease Diagnostics: Geographic Segmentation Analysis
 5.5 Genomics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Genomics: Geographic Segmentation Analysis
 5.6 Proteomics
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Proteomics: Geographic Segmentation Analysis
 5.7 Agriculture
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Agriculture: Geographic Segmentation Analysis
 5.8 Others
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Others: Geographic Segmentation Analysis

Chapter 6: Biochips Market by End User
 6.1 Biochips Market Snapshot and Growth Engine
 6.2 Biochips Market Overview
 6.3 Biotechnology & Pharmaceutical Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Biotechnology & Pharmaceutical Companies: Geographic Segmentation Analysis
 6.4 Hospitals & Diagnostics Centers
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hospitals & Diagnostics Centers: Geographic Segmentation Analysis
 6.5 Academic & Research Institutes
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Academic & Research Institutes: Geographic Segmentation Analysis
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Biochips Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 ILLUMINA
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 INC. (USA)
 7.4 AGILENT TECHNOLOGIES
 7.5 INC. (USA)
 7.6 THERMO FISHER SCIENTIFIC
 7.7 INC. (USA)
 7.8 PERKINELMER
 7.9 INC. (USA)
 7.10 BIO-RAD LABORATORIES
 7.11 INC. (USA)
 7.12 GE HEALTHCARE (USA)
 7.13 FLUIDIGM CORPORATION (USA)
 7.14 F. HOFFMANN-LA ROCHE AG (SWITZERLAND)
 7.15 SAMSUNG BIOLOGICS (SOUTH KOREA)
 7.16 ABBOTT LABORATORIES (USA)
 7.17 CEPHEID (USA)
 7.18 MERCK KGAA (GERMANY)
 7.19 RANDOX LABORATORIES (UK)
 7.20 AYOXXA BIOSYSTEMS GMBH (GERMANY)
 7.21 MICRONIT MICROTECHNOLOGIES B.V. (NETHERLANDS)
 7.22 OTHER KEY PLAYERS.

Chapter 8: Global Biochips Market By Region
 8.1 Overview
 8.2. North America Biochips Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product Type
  8.2.4.1 DNA Chip
  8.2.4.2 Protein Chip
  8.2.4.3 Lab-on-a-chip
  8.2.4.4 Others
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Drug Discovery & Development
  8.2.5.2 Disease Diagnostics
  8.2.5.3 Genomics
  8.2.5.4 Proteomics
  8.2.5.5 Agriculture
  8.2.5.6 Others
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Biotechnology & Pharmaceutical Companies
  8.2.6.2 Hospitals & Diagnostics Centers
  8.2.6.3 Academic & Research Institutes
  8.2.6.4 Others
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Biochips Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product Type
  8.3.4.1 DNA Chip
  8.3.4.2 Protein Chip
  8.3.4.3 Lab-on-a-chip
  8.3.4.4 Others
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Drug Discovery & Development
  8.3.5.2 Disease Diagnostics
  8.3.5.3 Genomics
  8.3.5.4 Proteomics
  8.3.5.5 Agriculture
  8.3.5.6 Others
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Biotechnology & Pharmaceutical Companies
  8.3.6.2 Hospitals & Diagnostics Centers
  8.3.6.3 Academic & Research Institutes
  8.3.6.4 Others
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Biochips Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product Type
  8.4.4.1 DNA Chip
  8.4.4.2 Protein Chip
  8.4.4.3 Lab-on-a-chip
  8.4.4.4 Others
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Drug Discovery & Development
  8.4.5.2 Disease Diagnostics
  8.4.5.3 Genomics
  8.4.5.4 Proteomics
  8.4.5.5 Agriculture
  8.4.5.6 Others
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Biotechnology & Pharmaceutical Companies
  8.4.6.2 Hospitals & Diagnostics Centers
  8.4.6.3 Academic & Research Institutes
  8.4.6.4 Others
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Biochips Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product Type
  8.5.4.1 DNA Chip
  8.5.4.2 Protein Chip
  8.5.4.3 Lab-on-a-chip
  8.5.4.4 Others
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Drug Discovery & Development
  8.5.5.2 Disease Diagnostics
  8.5.5.3 Genomics
  8.5.5.4 Proteomics
  8.5.5.5 Agriculture
  8.5.5.6 Others
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Biotechnology & Pharmaceutical Companies
  8.5.6.2 Hospitals & Diagnostics Centers
  8.5.6.3 Academic & Research Institutes
  8.5.6.4 Others
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Biochips Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product Type
  8.6.4.1 DNA Chip
  8.6.4.2 Protein Chip
  8.6.4.3 Lab-on-a-chip
  8.6.4.4 Others
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Drug Discovery & Development
  8.6.5.2 Disease Diagnostics
  8.6.5.3 Genomics
  8.6.5.4 Proteomics
  8.6.5.5 Agriculture
  8.6.5.6 Others
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Biotechnology & Pharmaceutical Companies
  8.6.6.2 Hospitals & Diagnostics Centers
  8.6.6.3 Academic & Research Institutes
  8.6.6.4 Others
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Biochips Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product Type
  8.7.4.1 DNA Chip
  8.7.4.2 Protein Chip
  8.7.4.3 Lab-on-a-chip
  8.7.4.4 Others
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Drug Discovery & Development
  8.7.5.2 Disease Diagnostics
  8.7.5.3 Genomics
  8.7.5.4 Proteomics
  8.7.5.5 Agriculture
  8.7.5.6 Others
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Biotechnology & Pharmaceutical Companies
  8.7.6.2 Hospitals & Diagnostics Centers
  8.7.6.3 Academic & Research Institutes
  8.7.6.4 Others
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research